CHO Pharma, Inc. (TPEX:6586)
85.00
-4.80 (-5.35%)
Nov 17, 2026, 2:00 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 18.19 billion as of November 17, 2026. It is the 13,516th most valuable company in the world and the 414th biggest in Taiwan. Its market cap has increased by 182.86% in one year.
Market Cap
18.19B
Enterprise Value
16.24B
Revenue
1.71M
Global Rank
Country Rank
#414 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 27, 2017, CHO Pharma's market cap has increased from 15.00B to 18.19B, an increase of 21.27%. That is a compound annual growth rate of 2.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 18.19B | 202.49% |
| Dec 31, 2025 | 6.01B | -45.44% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 22.18B |
| Steminent Biotherapeutics | 21.07B |
| Sunmax Biotechnology | 20.94B |
| TaiMed Biologics | 17.40B |
| EirGenix | 15.83B |
| Gongwin Biopharm Holdings | 15.14B |
| Medigen Vaccine Biologics | 14.79B |
| Lumosa Therapeutics | 14.64B |